Franklin Genomic Advancements Fund I (acc) USD Fonds 113697904 / LU2387456598
USD
-
USD
-
%
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Dokumente | Sharpe Ratio | |
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Anlageziel Franklin Genomic Advancements Fund I (acc) USD Fonds
The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.
Stammdaten
| Valor | 113697904 |
| ISIN | LU2387456598 |
| Fondsgesellschaft | Franklin Templeton International Services |
| Kategorie | Branchen: Gesundheitswesen |
| Währung | USD |
| Mindestanlage | 3’978’250.00 |
| VL-fähig? | Nein |
| Thesaurierend/Ausschüttend | Thesaurierend |
| Fondsmanager | Matthew J. Moberg |
Aktuelle Daten
| Fondsnote | - |
| Aktueller Rücknahmepreis | 6.56 |
| Fondsvolumen | 2’982’130.40USD |
| Total Expense Ratio (TER) | 0.85% |
Gebühren
| Verwaltungsgebühr | - |
| Depotbankgebühr | - |
| Rücknahmegebühr | - |
| Ausgabeaufschlag | - |
Basisdaten
| Auflagedatum | 15.10.2021 |
| Depotbank | J.P. Morgan SE, Luxembourg Branch |
| Zahlstelle | BNP Paribas Securities Services,Paris,succursale de Zurich |
| Domizil | Luxembourg |
| Geschäftsjahr | 30.06.2025 |
Performancedaten
| Veränderung Vortag | -0.08 USD (-1.20 %) |